
Author: Mary Moore RN


Researchers Develop a Genetic Test to Identify the Most Effective Antidepressant for Each Patient
Major depression is one of the biggest public health burdens. A Canadian study highlights the benefits of pharmacogenomic testing (a type of genetic testing) to identify the right antidepressant …Up to 50% of People Worldwide May Face a Mental Disorder by Age 75, Based on Data from 29 Countries
A recent cross-national analysis involving 29 countries brings to light a pressing issue in global mental health: the likelihood of developing a mental disorder by the age of 75. …Father of Modern Gender Reassignment: Dr. Georges Burou’s Groundbreaking Work in the Heart of Casablanca Morocco
In the 60s and 70s, for more than a decade, Casablanca Morocco became known worldwide for a very special kind of tourism. It was here, in this mythical city …Gilmore Health News: A Q&A Session on the Causes and Treatment of Dry Eyes
Dry eyes are a common problem that arises from the lack of proper lubrication of the eyes. It usually develops when the eyes don’t make enough tears or the …Novel Treatment For Progressive Pulmonary Fibrosis Gets Breakthrough Therapy Designation From the FDA
The U.S. Food and Drug Administration (FDA) has granted a novel antifibrotic Breakthrough Therapy designation. This move could speed up the therapy’s development for the treatment of people with …Study Reveals that Even 13 Days Post-Cold Exposure, You’re Still at Risk for Deadly Pneumonia!
Pneumonia, a prevalent respiratory ailment predominantly instigated by infectious agents, continually proves to be a pressing health concern across the globe. While numerous factors play a role in the …
Patisiran’s Potential in Tackling Transthyretin Cardiac Amyloidosis: Results from the APOLLO-B Trial
Cardiac complications continue to be at the forefront of medical challenges, with Transthyretin amyloidosis (ATTR amyloidosis) representing a significant concern. ATTR amyloidosis manifests through the accumulation of amyloid deposits …Preventing Ventilator-Associated Pneumonia: A Case for Inhaled Amikacin
Ventilator-associated pneumonia (VAP) remains a significant clinical concern in intensive care units worldwide. This nosocomial infection complicates the treatment trajectory of critically ill patients, prolonging hospital stays, increasing costs, …

